Deauville score evaluationof PET2 positive patients included in the H10 trial

Anne-Ségolène Cottereau (1, 2) , A. Versari (3) , A. Loft (4) , O. Casasnovas (5, 6) , M. Bellei (7) , R. Ricci (8, 9) , S. Bardet (10) , A. Castagnoli (11) , P. Brice (12) , J. M. M. Raemaekers (13) , Tiana Raveloarivahy (14) , Emelie van Zele (8) , L Chartier (15) , T. Vander Borght (16) , M Federico (7) , Martin Hutchings (4) , Umberto Ricardi (17) , M Meignan (18) , M. Andre (16)

1 AP-HP - Hôpital Cochin Broca Hôtel Dieu [Paris]
2 Hôpital Cochin [AP-HP]
3 Santa Maria Nuova Hospital
4 Rigshospitalet [Copenhagen]
5 LNC - Lipides - Nutrition - Cancer [Dijon - U1231]
6 CHU Dijon
7 UNIMORE - Università degli Studi di Modena e Reggio Emilia = University of Modena and Reggio Emilia
8 LYSARC - The Lymphoma Academic Research Organisation [Lyon]
9 CHU Henri Mondor [Créteil]
10 UNICANCER/CRLC - Centre Régional de Lutte contre le Cancer François Baclesse [Caen]
11 Ospedale Santo Stefano
12 AP-HP - Hopital Saint-Louis [AP-HP]
13 Radboud University [Nijmegen]
14 EORTC - European Organisation for Research and Treatment of Cancer [Bruxelles]
15 CHLS - Centre Hospitalier Lyon Sud [CHU - HCL]
16 CHU UCL Namur
17 UNITO - Università degli studi di Torino = University of Turin
18 LYSA-IM - LYSA Imaging (Créteil)

Mots clés: Radiology; Nuclear Medicine & Medical Imaging

Domaines: Imagerie; Médecine nucléaire

Anne-Ségolène Cottereau, A. Versari, A. Loft, O. Casasnovas, M. Bellei, et al.. Deauville score evaluationof PET2 positive patients included in the H10 trial. European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 (supl. 1), pp.S439. ⟨hal-01950182⟩